Trial Profile
A Randomised, Double-blind, Placebo-controlled Phase I Study to Determine the Safety and Efficacy of Recombinant Human Beta Defensin 2 (rHuB[beta]D2 cream) in the Treatment of Staphylococcus aureus and other Infections in the Skin of Patients with Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Beta defensin 2 (Primary)
- Indications Atopic dermatitis; Skin infections; Staphylococcal infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Planton
- 27 Apr 2011 New trial record